What is Emmessar Biotech & Nutrition Ltd (524768) share price return in the past 10 years?

Emmessar Biotech & Nutrition Ltd share price has appreciated 6.3% annually (CAGR) over the past ten years.

What is the share price of Emmessar Biotech & Nutrition Ltd (524768)?

Company share prices are keep on changing according to the market conditions. The current trading price of Emmessar Biotech & Nutrition Ltd (524768) on 04-Jun-2026 16:59:59 at 16:59 is 25.00.

What is the P/E ratio of Emmessar Biotech & Nutrition?

The latest standalone P/E ratio of Emmessar Biotech & Nutrition as of 04-Jun-2026 is 28.58.

What is the P/B ratio of Emmessar Biotech & Nutrition Ltd (524768)?

The latest standalone P/B ratio of Emmessar Biotech & Nutrition Ltd (524768) as of 04-Jun-2026 is 1.54.

What is the 52-week high and low of Emmessar Biotech & Nutrition Ltd (524768)?

The 52-week high of Emmessar Biotech & Nutrition Ltd (524768) is Rs. 42.90 and the 52-week low is Rs. 18.42.

Emmessar Biotech & Nutrition Ltd (524768) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Emmessar Biotech & Nutrition Ltd (524768)
Brand: Emmessar Biotech & Nutrition

Key Metrics

Valuation Multiples

Market Cap

₹12 Cr.

Current Price

₹25

52-Week Low / High

₹18 / 43

TTM EPS

₹0.9

TTM Sales

₹0.4 Cr.

Book Value per Share

₹16.2

P/E Ratio

28.58

Higher than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

1.54

Lower than its 5-year historical median

Price to Sales (P/S)

33.67

Higher than its 5-year historical median

EV/EBITDA

7.58

In line with its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

4.19%

Underperforms industry median

Return on Capital Employed (ROCE)

12.63%

Outperforms industry median

Return on Assets (ROA)

3.48%

Operating Profit Margin

-155.5%

Net Profit Margin

51.76%

Gross Profit Margin

172.8%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

8.93%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-57.33%

Asset Quality

Promoter Holding

59.53%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹3 Cr.

Equity

₹5 Cr.

Face Value

₹10

All Time Low / High

₹1.00 / 64.00

Emmessar Biotech & Nutrition stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Emmessar Biotech & Nutrition Ltd a good quality company?

Emmessar Biotech & Nutrition Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Emmessar Biotech & Nutrition Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Emmessar Biotech & Nutrition Ltd vs industry peers?

Emmessar Biotech & Nutrition Ltd revenue CAGR is -29.08%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Emmessar Biotech & Nutrition Ltd?

Promoters hold 59.53% of the Emmessar Biotech & Nutrition Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Emmessar Biotech & Nutrition Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 6% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	-59.4%	79.5%	31.5%	9%	18.9%	45.3%	15.7%	15%	11.4%	12.6%	-
Value Creation Index ⓘ	-5.2	4.7	1.3	-0.4	0.4	2.2	0.1	0.1	-0.2	-0.1	-
Growth Parameters ⓘ
Sales ⓘ	2	2.6	1.3	0.6	3.4	7	0.4	1	0.6	0.6	0
Sales YoY Gr.	-	33.5%	-52.5%	-49.6%	439.7%	105.6%	-94.9%	183.3%	-45.1%	8.9%	-
Adj EPS ⓘ	0.4	2.4	1.8	1.5	1.9	2.9	0.6	1	1.5	0.6	0.9
YoY Gr.	-	555.6%	-22.5%	-19.7%	27.9%	54.3%	-79.7%	69.5%	50%	-58%	-
BVPS (₹) ⓘ	1.8	4.2	6	7	8.5	11.4	12.4	13.3	14.8	15.4	16.2
Adj Net Profit ⓘ	0.2	1.2	0.9	0.7	0.9	1.5	0.3	0.5	0.8	0.3	0
Cash Flow from Ops. ⓘ	0.4	0.8	0.7	0.4	1	0.5	2.3	0.4	0.6	0.2	-
Debt/CF from Ops. ⓘ	0	0	0	0.2	0	0	0	0.2	0.2	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-12.2%	-29.1%	19.2%	8.9%
Adj EPS ⓘ	6.4%	-19.6%	2.2%	-58%
BVPSⓘ	26.8%	12.6%	7.7%	4.1%
Share Price	6.3%	-8.6%	0.4%	-23.7%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	15.6	78.6	36	22.6	24.1	29.1	5	7.8	10.7	4.2	5.5
Op. Profit Mgn % ⓘ	0.6	8.6	-33.3	-101.6	-11.9	12.1	-242.5	-67.1	-194.3	-155.5	-365.3
Net Profit Mgn % ⓘ	9	44.8	72.9	116.5	27.6	20.7	80.9	49.2	135.3	51.6	117.6
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	175	152	333	905	193	124	2,044	326	512	418	3,783
Cash Conv. Cycle ⓘ	64	40	39	187	47	57	1,347	38	84	74	3,571

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	1.97	2.63	1.25	0.63	3.40	6.99	0.36	1.02	0.56	0.61
Operating Expenses ⓘ +	1.96	2.41	1.67	1.27	3.80	6.14	1.26	1.71	1.64	1.56
Manufacturing Costs	0.41	0.73	0.39	0.25	1.37	1.63	0.04	0.05	0.05	0.05
Material Costs	1	0.98	0.63	0.12	1.54	3.53	0.13	0.40	0.20	0.18
Employee Cost	0.31	0.39	0.41	0.58	0.58	0.64	0.77	0.84	0.96	0.93
Other Costs ⓘ	0.24	0.31	0.24	0.32	0.31	0.34	0.32	0.42	0.43	0.40
Operating Profit ⓘ	0.01	0.23	-0.42	-0.64	-0.40	0.85	-0.89	-0.69	-1.08	-0.95
Operating Profit Margin (%)	0.6%	8.6%	-33.3%	-101.0%	-11.9%	12.1%	-245.0%	-67.6%	-194.0%	-155.0%
Other Income ⓘ +	0.26	0.98	1.27	1.30	1.47	1.47	1.92	1.75	1.99	2.01
Exceptional Items ⓘ	-0.92	0	0	-0.29	-0.26	0	0	0	0	0
Interest ⓘ	0	0.01	0	0	0	0	0	0	0	0
Depreciation ⓘ	0.03	0.01	0.05	0.08	0.06	0.06	0.09	0.09	0.10	0.10
Profit Before Tax ⓘ	-0.68	1.18	0.80	0.29	0.74	2.25	0.93	0.97	0.81	0.96
Tax ⓘ	-0.21	0	-0.12	-0.24	-0.02	0.80	0.46	0.46	0.06	0.64
Profit After Tax	-0.47	1.18	0.91	0.53	0.75	1.45	0.48	0.50	0.75	0.32
PAT Margin (%)	-23.6%	44.8%	72.9%	84.7%	22.2%	20.7%	130.3%	49.4%	135.0%	51.8%
Adjusted EPS (₹)	-0.9	2.4	1.8	1.1	1.5	2.9	1.0	1.0	1.5	0.6
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Emmessar Biotech&Nut - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	0.91	2.09	2.98	3.51	4.26	5.70	6.17	6.66	7.40	7.71
Share Capital ⓘ	5	5	5	5	5	5	5	5	5	5
Reserves ⓘ	-4.09	-2.91	-2.01	-1.49	-0.73	0.70	1.17	1.67	2.41	2.71
Debt +	0	0	0	0.07	0	0	0	0.08	0.11	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0	0	0	0.07	0	0	0	0.08	0.11	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.20	0.20	0.01	0.58	0.80	0.50	0.02	0	0.01	0
Others Liabilities ⓘ	1.05	0.81	0.69	0.53	0.35	1.29	1.41	1.35	1.25	1.71
Total Liabilities ⓘ	2.16	3.11	3.68	4.68	5.41	7.49	7.60	8.09	8.77	9.42
Fixed Assets
Net Fixed Assets ⓘ +	0.73	0.72	2.25	1.99	1.91	1.86	1.46	1.40	1.31	1.22
Gross Block	1.31	1.30	2.88	2.63	2.60	2.60	2.02	2.04	2.04	2.04
Accumulated Depreciation	0.58	0.58	0.63	0.64	0.68	0.74	0.56	0.65	0.74	0.82
CWIP ⓘ	0	0.80	0	0	0	0	0	0	0	0
Investments ⓘ	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Inventories	0.36	0.32	0.09	0.73	1.15	0.07	0.07	0.14	0.09	0.12
Trade Receivables	0.36	0.04	0.03	0.04	0.03	2.71	0.01	0.01	0.02	0.02
Cash Equivalents ⓘ	0.43	0.32	0.27	0.71	1.88	2.47	4.58	5.19	6.18	6.87
Others Assets ⓘ	0.27	0.89	1.03	1.21	0.44	0.38	1.47	1.35	1.16	1.17
Total Assets ⓘ	2.16	3.11	3.68	4.68	5.41	7.49	7.60	8.09	8.77	9.42

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.44	0.75	0.74	0.39	1.03	0.47	2.27	0.38	0.64	0.22
PBT ⓘ	-0.68	1.18	0.80	0.58	1	2.25	0.93	0.97	0.81	0.96
Adjustment ⓘ	0.73	0.06	0.01	-0.07	-0.31	-0.07	-0.13	-0.15	-0.42	-0.37
Changes in Working Capital ⓘ	0.39	-0.45	-0.02	-0.12	0.34	-1.61	1.76	-0.5	0.24	-0.35
Tax Paid ⓘ	0	-0.04	-0.05	0	0	-0.10	-0.29	0.06	0.02	-0.02
Cash Flow From Investing Activity ⓘ +	-0.46	-0.74	-0.69	-0.37	-1.06	0.01	-2.61	-0.55	-0.64	-0.23
Capex	-0.02	-0.01	-0.78	-0	-0	-0	-0.31	-0.03	0	0
Net Investments	-0	-0	0.08	-0.41	-1.19	-0.11	-2.45	-0.78	-0.99	-0.69
Others ⓘ	-0.44	-0.74	0.01	0.04	0.14	0.12	0.14	0.26	0.35	0.46
Cash Flow From Financing Activity ⓘ +	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0	0	-0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0	0	0
Net Cash Flow ⓘ	-0.02	0.01	0.05	0.01	-0.03	0.48	-0.34	-0.17	0	-0

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-40.75	78.73	36	16.42	19.4	29.1	8.01	7.85	10.66	4.19
ROCE (%)	-59.37	79.46	31.46	9	18.87	45.29	15.71	14.99	11.42	12.63
Asset Turnover Ratio	0.89	1.03	0.39	0.15	0.67	1.08	0.05	0.13	0.07	0.07
PAT to CFO Conversion(x)	N/A	0.64	0.81	0.74	1.37	0.32	4.73	0.76	0.85	0.69
Working Capital Days
Receivable Days	36	27.40	10.30	20.80	3.50	71.40	1,361.90	4.20	10.90	12
Inventory Days	93.30	45.70	56.20	236.30	100.90	31.80	67.80	36.60	74.10	63.60
Payable Days	93	75.60	61.20	856.60	163.30	67.20	752.50	0	16.80	12.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Emmessar Biotech & Nutrition Ltd FAQs

The current trading price of Emmessar Biotech&Nut on 04-Jun-2026 16:59 is ₹25.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of Emmessar Biotech&Nut stood at ₹12.49 Cr

The latest P/E ratio of Emmessar Biotech&Nut as of 03-Jun-2026 is 28.58.

The latest P/B ratio of Emmessar Biotech&Nut as of 03-Jun-2026 is 1.54.

The 52-week high of Emmessar Biotech&Nut is ₹42.90 and the 52-week low is ₹18.42.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Emmessar Biotech&Nut is ₹0.37 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Emmessar Biotech & Nutrition Ltd is a good quality company.

The key valuation ratios of Emmessar Biotech & Nutrition Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Emmessar Biotech & Nutrition Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi .

When there was a realisation that some of the Speciality Chemicals developed in our R&D and exported to USA & Europe were being used in Healthcare formulations, the Company decided to re-orient itself and enter the Healthcare business, which is poised for phenomenal growth in the coming decades.

Concurrently the company also realised that some of the Speciality Chemicals are actually Vital Micro Nutrients, which are being used in the research worldwide as tools of Biotechnology, the Company took a conscious decision to enter the field of Biotechnology & Healthcare.

To ensure that the name is representative of its activity, the company's name was changed from Emmessar Chemical Industries Ltd., to Emmessar Biotech & Nutrition Ltd., on 7th April 2000.

In the process of pursuing its own R&D and exploring commercial market potentials for their products in the field of Healthcare, the company came across another reputed company in USA Vibrant Life in California.

Intense exchange of ideas & technical information between Emmessar Biotech & Nutrition Ltd., & Vibrant Life, resulted in development of several new concepts and new technologies - combining different schools of thought such as Nutraceuticals, Cosmeceuticals, Ayurveda & Biotechnology.

The company has developed many products covering different areas of healthcare that include obstinate Skin problems & debilitating chronic physical ailments.

Emmessar Biotech & Nutrition Ltd., is a Public Limited Company, with the Paid-up Share Capital of about Rs. 50.00 million (over $ 1.00 million). The Stocks of Emmessar Biotech & Nutrition Ltd., are traded in The Bombay Stock Exchange Ltd.

Product range of the company includes:

Present products

Calmcream
Magicream
Supportt Joint
Supportt Bones
Micro Nutrients
Speciality Chemicals
CC-99
Biosulf
Calmcream

Products planned to be launched in future

Ayurvedic Creams
Nutraceutical Creams
Cosmeceutical Creams
Oral Supplements

Emmessar Biotech & Nutrition Ltd (524768)

Emmessar Biotech & Nutrition Ltd (524768)

Emmessar Biotech & Nutrition stock performance